Transdermal administration of buprenorphine

Details Transdermal administration of buprenorphine Transdermal administration of buprenorphine

A - Human Necessities

61

K

A61K 31/46 (2006.01) A61K 9/70 (2006.01) A61K 31/485 (2006.01) A61K 47/12 (2006.01) A61K 47/14 (2006.01) A61M 37/00 (2006.01)

Patent

CA 2085126

2085126 9119474 PCTABS00008 Method and laminated composite (10) for administering buprenorphine transdermally to treat pain. The composite comprises an impermeable backing layer (11) and a reservoir layer (12) containing buprenorphine a release liner lamina (13) and optionally a permeation enhancer combined with a pressure-sensitive adhesive with the amounts of buprenorphine and optional enhancer being sufficient to cause the buprenorphine to pass through the skin at a rate in excess of about 0.05 mcg/cm2/hr.

Affiliated with

Also associated with

Rating

Transdermal administration of buprenorphine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transdermal administration of buprenorphine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal administration of buprenorphine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1520040